An assessment of asthmatic patients at four Western Cape community pharmacies

South African Medical Journal

Volumn 88, Issue 3, 1998, Pages 262-266

  Bheekie, A ^a   Syce, J A ^b   Weinberg, E G ^c,d  

^a University of the Western Cape ^*

^b UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^c RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHILD; COUGHING; DYSPNEA; FEMALE; GENERAL PRACTITIONER; HEALTH CARE UTILIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PHARMACY; QUESTIONNAIRE; SOUTH AFRICA; WHEEZING;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AIRWAY OBSTRUCTION; ASTHMA; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PHARMACIES; QUESTIONNAIRES; SEX FACTORS; SOCIOECONOMIC FACTORS; SOUTH AFRICA;

EID: 0031961386     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Burkholter D, Schiffer P. The epidemiology of atopic diseases in Europe. ACI News 1995; 7(4): 113-125.
2. Keeley D. How to achieve better outcome in the treatment of asthma in general practice. BMJ 1993; 307: 1261-1263.
3. Henry RL, Fitzclarence CAB, Henry DA, et al. What do health care professionals know about asthma? J Paediatr Child Health 1993; 29: 32-35.
4. Barnes PJ. Poorly perceived asthma. Thorax 1992; 47: 408-409.
5. Fassihi AR, Osman LM. The pharmacist's role in rational self-medication. An important aspect of cost-effective health care. S Afr Pharm J 1992; Sept: 259-261.
6. Henry DA, Sutherland D, Francis L, et al. The use of non-prescription salbutamol inhalers by asthmatic patients in the Hunter Valley, New South Wales. Med J Aust 1989; 150: 445-449.
7. Gibson P, Henry D, Francis L, et al. Association between availability of non-prescription β agonist inhalers and undertreatment of asthma. BMJ 1993; 306: 1514-1518.
8. National Asthma Campaign. Pharmacist's Asthma Management Handbook. The Management Plan. 2nd Handbook, Melbourne: National Asthma Campaign (Ltd) Australia, 1994.
9. National Heart, Lung and Blood Institute (NHLBI). National Institutes of Health, Bethesda, Maryland 20892. International consensus report on diagnosis and treatment of asthma (Publication No. 92-3091). Eur Respir J 1992; 5: 601-641.
10. Tse M, Bridges-Webb C. Asthma management in general practice. Med J Aust 1993; 158: 766-770.
11. Hargreave FE, Dolovich J, Newhouse M. The assessment and treatment of asthma: A conference report. J Allergy Clin Immunol 1990; 85(6): 1098-1111.
12. Gregg I, Nunn AJ. Peak expiratory flow in normal subjects. BMJ 1973; 3: 282-284.
13. Joubert JR, Brink S, Hentzen GM. Allergic asthma in different population groups in the Western Cape. S Afr Med J 1988; 73: 150-154.
14. Ehrlich RI, Weinberg EG. Increase in hospital admissions for acute childhood asthma in Cape Town, 1978 - 1990. S Afr Med J 1994; 84: 263-266.
15. Timonen KL, Pekkanen J, Korppi M, et al. Prevalence and characteristics of children with chronic respiratory symptoms in eastern Finland. Eur Respir J 1995; 8: 1155-1160.
16. Crane J, Pearce N, Burgess C, et al. Asthma and the β agonist debate. Thorax 1995; 50: suppl, S5-S10.
17. Van Schayck CP. Diagnosis of asthma and chronic obstructive pulmonary disease in general practice. Br J Gen Pract 1996; 46: 193-197.